133 related articles for article (PubMed ID: 3086766)
1. Occurrence and distribution of 5-S-cysteinyl derivatives of dopamine, dopa and dopac in the brains of eight mammalian species.
Fornstedt B; Rosengren E; Carlsson A
Neuropharmacology; 1986 Apr; 25(4):451-4. PubMed ID: 3086766
[TBL] [Abstract][Full Text] [Related]
2. An improved HPLC-electrochemical detection method for measuring brain levels of 5-S-cysteinyldopamine, 5-S-cysteinyl-3,4-dihydroxyphenylalanine, and 5-S-cysteinyl-3,4-dihydroxyphenylacetic acid.
Fornstedt B; Bergh I; Rosengren E; Carlsson A
J Neurochem; 1990 Feb; 54(2):578-86. PubMed ID: 2105377
[TBL] [Abstract][Full Text] [Related]
3. Oxidation of dopamine and related catechols in dopaminergic brain regions in Parkinson's disease and during ageing in non-Parkinsonian subjects.
Fornstedt Wallin B
J Neural Transm (Vienna); 2024 Mar; 131(3):213-228. PubMed ID: 38238531
[TBL] [Abstract][Full Text] [Related]
4. In vivo autoxidation of dopamine in guinea pig striatum increases with age.
Fornstedt B; Pileblad E; Carlsson A
J Neurochem; 1990 Aug; 55(2):655-9. PubMed ID: 2370552
[TBL] [Abstract][Full Text] [Related]
5. A marked rise in 5-S-cysteinyl-dopamine levels in guinea-pig striatum following reserpine treatment.
Fornstedt B; Carlsson A
J Neural Transm; 1989; 76(2):155-61. PubMed ID: 2496196
[TBL] [Abstract][Full Text] [Related]
6. The apparent autoxidation rate of catechols in dopamine-rich regions of human brains increases with the degree of depigmentation of substantia nigra.
Fornstedt B; Brun A; Rosengren E; Carlsson A
J Neural Transm Park Dis Dement Sect; 1989; 1(4):279-95. PubMed ID: 2597314
[TBL] [Abstract][Full Text] [Related]
7. Effects of inhibition of monoamine oxidase on the levels of 5-S-cysteinyl adducts of catechols in dopaminergic regions of the brain of the guinea pig.
Fornstedt B; Carlsson A
Neuropharmacology; 1991 May; 30(5):463-8. PubMed ID: 1907723
[TBL] [Abstract][Full Text] [Related]
8. Determination of DOPA, dopamine, and 5-S-cysteinyl-DOPA in plasma, urine, and tissue samples by high-performance liquid chromatography with electrochemical detection.
Ito S; Kato T; Maruta K; Fujita K; Kurahashi T
J Chromatogr; 1984 Nov; 311(1):154-9. PubMed ID: 6440898
[No Abstract] [Full Text] [Related]
9. Synthesis of 5-S-L-cysteinyl-glycine-L-dopa, a natural substrate for serum and melanocyte dipeptidase.
Kågedal B; Gawelin AL; Pettersson A
Anal Biochem; 1987 Aug; 165(1):167-74. PubMed ID: 3120620
[TBL] [Abstract][Full Text] [Related]
10. Sensitive high-performance liquid chromatographic method for the determination of 5-S-cysteinyldopamine, 5-S-cysteinyl-3,4-dihydroxyphenylacetic acid and 5-S-cysteinyl-3,4-dihydroxyphenylalanine.
Fornstedt-Wallin B; Bergh I
J Chromatogr B Biomed Appl; 1995 Jan; 663(1):9-14. PubMed ID: 7704217
[TBL] [Abstract][Full Text] [Related]
11. Formation of cysteine conjugates from dihydroxyphenylalanine and its S-cysteinyl derivatives by peroxidase-catalyzed oxidation.
Ito S; Fujita K
Biochim Biophys Acta; 1981 Jan; 672(2):151-7. PubMed ID: 6784771
[TBL] [Abstract][Full Text] [Related]
12. Identification of 5-S-cysteinyldopa by high performance liquid chromatography in biopsies from patients with dysplastic melanocytic nevi.
Halldin MM; Cook WS; Kawashima T; Crutcher WA; Fukuyama K
Cancer Res; 1987 Jan; 47(2):636-8. PubMed ID: 3098416
[TBL] [Abstract][Full Text] [Related]
13. Conjugates of catecholamines with cysteine and GSH in Parkinson's disease: possible mechanisms of formation involving reactive oxygen species.
Spencer JP; Jenner P; Daniel SE; Lees AJ; Marsden DC; Halliwell B
J Neurochem; 1998 Nov; 71(5):2112-22. PubMed ID: 9798937
[TBL] [Abstract][Full Text] [Related]
14. 5-S-cysteinyldopa, dopa, and dopamine in the kidney and some other tissues.
Agrup G; Hansson C; Rorsman H; Rosengren E
Acta Derm Venereol; 1980; 60(1):63-4. PubMed ID: 6153836
[TBL] [Abstract][Full Text] [Related]
15. Evidence of dopa in the nerves of sea anemones.
Carlberg M
J Neural Transm; 1983; 57(1-2):75-84. PubMed ID: 6137512
[TBL] [Abstract][Full Text] [Related]
16. A pulse radiolysis investigation of the oxidation of the melanin precursors 3,4-dihydroxyphenylalanine (dopa) and the cysteinyldopas.
Thompson A; Land EJ; Chedekel MR; Subbarao KV; Truscott TG
Biochim Biophys Acta; 1985 Nov; 843(1-2):49-57. PubMed ID: 3933569
[TBL] [Abstract][Full Text] [Related]
17. 5-S-Cysteinyldopa in ganglion stellatum.
Fehling C; Hansson C; Poulsen J; Rorsman H; Rosengren E
J Neural Transm; 1981; 52(3):251-7. PubMed ID: 6796651
[TBL] [Abstract][Full Text] [Related]
18. Intracellular distribution of dopa and 5-S-cysteinyldopa in Harding-Passey melanoma.
Agrup G; Falck B; Rorsman H; Rosengren AM; Rosengren E
Acta Derm Venereol; 1977; 57(4):313-5. PubMed ID: 70922
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antitumor activity of cysteinyl-3,4-dihydroxyphenylalanines and related compounds.
Ito S; Inoue S; Yamamoto Y; Fujita K
J Med Chem; 1981 Jun; 24(6):673-7. PubMed ID: 6788955
[TBL] [Abstract][Full Text] [Related]
20. Detection of 5-S-cysteinyldopamine in human brain.
Rosengren E; Linder-Eliasson E; Carlsson A
J Neural Transm; 1985; 63(3-4):247-53. PubMed ID: 3840838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
